| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
4,911 |
3,783 |
$535K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,644 |
6,457 |
$182K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,015 |
3,308 |
$164K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
3,133 |
2,546 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
136 |
128 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
591 |
416 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,025 |
832 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
383 |
307 |
$4K |
| 99215 |
Prolong outpt/office vis |
118 |
52 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
26 |
24 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
43 |
37 |
$912.62 |
| 87807 |
|
89 |
73 |
$715.00 |
| 90682 |
|
19 |
18 |
$670.78 |
| 99383 |
|
27 |
25 |
$487.40 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
19 |
16 |
$228.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
15 |
13 |
$108.00 |
| 81003 |
|
53 |
45 |
$93.70 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
21 |
13 |
$62.86 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13 |
13 |
$60.40 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
12 |
$35.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
70 |
57 |
$27.12 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
20 |
12 |
$17.28 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
3,504 |
2,877 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,000 |
824 |
$0.00 |
| 3079F |
|
43 |
40 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
1,390 |
1,106 |
$0.00 |
| 1125F |
|
147 |
124 |
$0.00 |
| 3074F |
|
44 |
39 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
194 |
131 |
$0.00 |
| 1159F |
|
77 |
59 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
13 |
12 |
$0.00 |
| 1160F |
|
63 |
45 |
$0.00 |
| 3077F |
|
29 |
27 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16 |
12 |
$0.00 |
| 0521F |
|
26 |
18 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
14 |
12 |
$0.00 |
| 3078F |
|
27 |
25 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
30 |
27 |
$0.00 |